SCHEMBL6206654

SCHEMBL6206654

CNCC(c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.50
PRMT6 Q96LA8 2/20 0.50
GRIN2B Q13224 6/20 0.46
ADRA2A P08913 5/20 0.46
HTR2A P28223 5/20 0.46
ADRA1A P35348 5/20 0.46
SLC6A2 P23975 5/20 0.46
SLC6A4 P31645 5/20 0.46
SLC6A3 Q01959 5/20 0.46
KCNH2 Q12809 5/20 0.46
GRIN1 Q05586 4/20 0.46
HTR2B P41595 4/20 0.46
CYP3A4 P08684 4/20 0.46
CYP2D6 P10635 4/20 0.46
SIGMAR1 Q99720 3/20 0.46
GRIN2D O15399 2/20 0.46
HTR1A P08908 2/20 0.46
GRIN2A Q12879 2/20 0.46
GRIN2C Q14957 2/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207015 0.84 SLC6A2 (0.46) CARM1PRMT6SLC6A2SLC6A4SLC6A3
SCHEMBL6007913 0.81 CARM1 (0.49) CARM1PRMT6SIGMAR1
Hydrochloric Acid SCHEMBL8905427 0.80 CARM1 (0.53) CARM1PRMT6GRIN2BADRA1ASLC6A2
SCHEMBL10732947 0.78 GRIN2B (0.71) GRIN2BADRA2AHTR2AADRA1ASLC6A2
SCHEMBL8784212 0.77 TACR1 (0.64) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL7815365 0.75 PRMT6 (0.59) CARM1PRMT6GRIN2BADRA1ASLC6A2
SCHEMBL6208623 0.75 OPRL1 (0.54) SLC6A2SLC6A4SLC6A3KCNH2CYP3A4
Hydrochloric Acid SCHEMBL8911045 0.74 GRIN2B (0.43) GRIN2BADRA2AHTR2AADRA1ASLC6A2
SCHEMBL5757908 0.73 CARM1 (0.59) CARM1PRMT6GRIN2BADRA2AHTR2A
SCHEMBL5759400 0.73 CCR3 (0.45) KCNH2SIGMAR1LMNAADRB1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709375-B1 Therapeutic heterocycles ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
US-6147083-A NOVEL SUBSTITUTED 1,2-ETHANEDIAMINE DERIVATIVES WHICH ANTAGONIZE THE PHARMACOLOGICAL ACTIONS OF THE ENDOGENOUS NEUROPEPTIDE TACHYKININS KNOWN AS NEUROKININS, USEFUL FOR THE TREATMENT OF ASTHMA, ETC. ZENECA LIMITED (GB) 2000-11-14 US disclosed
US-5998444-A ANTIASTHMA AGENTS; NEUROKININ ANTAGONIST ZENECA LTD. (GB) 1999-12-07 US disclosed
US-5710169-A NEUROKININ ANTAGONISTS; ANTIHISTAMINES, BRONCHODILATOR AGENTS; ASTHMA ZENECA LIMITED (GB) 1998-01-20 US disclosed
EP-0709375-A2 Therapeutic heterocycles ZENECA LIMITED (GB) 1996-05-01 EP disclosed